Related Experiment Video
Updated: Feb 28, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
Cutaneous and mucosal ulceration associated with the use of leflunomide in three dogs
Louis F Roussille1, Elizabeth Parsley1, Claire L Fellman1
1Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, United States.
Abstract:
Oral and cutaneous ulceration and drug-induced liver injury (DILI) are uncommon adverse drug reactions (ADRs) to leflunomide use in humans. Reports of leflunomide hepatotoxicity in dogs exist but ulceration has not been described in animals. This case series includes a 1.5-year-old male neutered Bernese Mountain Dog, a 7-year-old female spayed Australian Shepherd, and a 1-year-old male neutered mixed-breed dog that were administered leflunomide for immune-mediated conditions. All developed deep ulcerated lesions affecting either the tongue, skin, or both. One dog had concurrent severe DILI. The Naranjo probability scale for ADR suggested the signs were possibly (n = 1) or probably (n = 2) attributed to leflunomide administration. Ulcerated lesions resolved within weeks and hepatotoxicosis within months after discontinuation of leflunomide administration. This case series indicates that oral and cutaneous ulcers are potential ADRs to leflunomide and provides histological documentation of a leflunomide-induced liver injury.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

